Home » Topics » Regulatory

Regulatory
RSS

FDA approves Tymlos for postmenopausal women with osteoporosis at high risk for fracture

May 3, 2017

FDA grants accelerated approval to Alunbrig for ALK-positive NSCLC

May 2, 2017

FDA approves Rydapt for patients with newly diagnosed AML with FLT3 mutation

May 2, 2017

FDA grants accelerated approval to Imfinzi for previously treated bladder cancer

May 2, 2017

FDA approves Stivarga for second-line treatment of hepatocellular carcinoma

April 28, 2017

FDA approves Brineura to treat CLN2 disease

April 28, 2017

FDA grants accelerated approval to Tecentriq for bladder cancer not treatable with cisplatin

April 18, 2017

FDA grants approval for Ingrezza capsules for adults with tardive dyskinesia

April 12, 2017

FDA approves Austedo to treat chorea associated with Huntington's disease

April 4, 2017

European Commission approves Tafinlar with Mekinist for BRAF V600-positive NSCLC

April 3, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 21, 2025.
Crinetics’ TSHR antagonist demonstrates efficacy in thyroid autoimmune disorders
BioWorld Science
Graves disease (GD)-associated hyperthyroidism is an autoimmune disorder characterized by the presence of autoantibodies that stimulate the thyroid-stimulating...
TIM3 blockade could halt breast cancer before it spreads
BioWorld Science
In the current landscape of cancer research, much attention is focused on the tumor microenvironment (TME) at both the primary site and established metastases....
MTMR14 downregulation aggravates COPD progression
BioWorld Science
Chronic obstructive pulmonary disease (COPD) is a respiratory disease characterized by chronic inflammation and structural damage to the alveoli, with...